Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8521468 | 1.00 | CES2 (0.42) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL25950632 | 0.83 | CES2 (0.42) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL19736033 | 0.82 | CES2 (0.41) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL20203168 | 0.80 | CES2 (0.40) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL23894886 | 0.78 | CES2 (0.37) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL24916372 | 0.76 | MEN1 (0.37) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL23346658 | 0.74 | MEN1 (0.36) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL22924889 | 0.73 | CES2 (0.41) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL10448099 | 0.73 | CES2 (0.41) | CES2GGPS1MEN1KMT2A | |
| SCHEMBL17360709 | 0.73 | CES2 (0.42) | CES2GGPS1FDPSMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802123-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20230043088-A1 | Organic Light Emitting Device | LG CHEM, LTD. (KR) | 2023-02-09 | — | — | US | disclosed |
| US-20210280794-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
| US-11081655-B2 | Heterocyclic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2021-08-03 | — | — | US | disclosed |
| US-10700289-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2020-06-30 | — | — | US | disclosed |
| US-10461259-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2019-10-29 | — | — | US | disclosed |
| US-10439153-B2 | Compound and organic solar cell comprising same | LG CHEM, LTD. (KR) | 2019-10-08 | — | — | US | disclosed |
| US-10355225-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-07-16 | — | — | US | disclosed |
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
| US-20180076395-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
| US-20180069184-A1 | COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114923-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | CES2 1990/4885GGPS1 536/4885FDPS 1203/4885 |
| US-11802123-B2 | Heterocyclic compound and organic light emitting device comprising the same | CRY1, CRY2, PPOX | CES2 1421/4885GGPS1 65/4885FDPS 110/4885 |
| US-20210280794-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, AOX1 | CES2 760/4885GGPS1 89/4885FDPS 376/4885 |
| US-10461259-B2 | Organic light emitting device | CRY1, CRY2, MAP1LC3C | CES2 576/4885GGPS1 468/4885FDPS 669/4885 |
| US-10439153-B2 | Compound and organic solar cell comprising same | OR10J3, SUN2, CRY2 | CES2 3686/4885GGPS1 1880/4885FDPS 709/4885 |
| US-10355225-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | CES2 1990/4885GGPS1 536/4885FDPS 1203/4885 |
| US-11081655-B2 | Heterocyclic compound and organic light emitting device using the same | CRY1, CYP1B1, CYBA | CES2 742/4885GGPS1 47/4885FDPS 354/4885 |
| US-20180076395-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | CES2 1990/4885GGPS1 536/4885FDPS 1203/4885 |
| US-20180069184-A1 | COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | OR10J3, SUN2, CRY2 | CES2 3686/4885GGPS1 1880/4885FDPS 709/4885 |
| US-10700289-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | CES2 1990/4885GGPS1 536/4885FDPS 1203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.